Does NILOTINIB Cause Hyperkeratosis? 12 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 12 reports of Hyperkeratosis have been filed in association with NILOTINIB (nilotinib). This represents 0.1% of all adverse event reports for NILOTINIB.
12
Reports of Hyperkeratosis with NILOTINIB
0.1%
of all NILOTINIB reports
0
Deaths
6
Hospitalizations
How Dangerous Is Hyperkeratosis From NILOTINIB?
Of the 12 reports, 6 (50.0%) required hospitalization.
Is Hyperkeratosis Listed in the Official Label?
Yes, Hyperkeratosis is listed as a known adverse reaction in the official FDA drug label for NILOTINIB.
What Other Side Effects Does NILOTINIB Cause?
Death (2,667)
Fatigue (1,679)
Rash (1,250)
Nausea (1,180)
Headache (1,177)
Pain (1,169)
Dyspnoea (1,070)
Diarrhoea (998)
Drug ineffective (992)
Malaise (961)
What Other Drugs Cause Hyperkeratosis?
CABOZANTINIB S-MALATE (411)
ADALIMUMAB (332)
SUNITINIB MALATE (170)
ETANERCEPT (168)
SORAFENIB (150)
METHOTREXATE (149)
VEMURAFENIB (145)
REGORAFENIB (136)
RIPRETINIB (124)
RITUXIMAB (121)
Which NILOTINIB Alternatives Have Lower Hyperkeratosis Risk?
NILOTINIB vs NIMESULIDE
NILOTINIB vs NIMODIPINE
NILOTINIB vs NINTEDANIB
NILOTINIB vs NINTEDANIB ESYLATE
NILOTINIB vs NIRAPARIB